Pharmaceutical
Cipla Q2 net profit rises 17% to Rs 1,303 cr; income from operations at Rs 7,051 cr
Major fire in Atchutapuram pharma unit kills 17 persons, injures 33
Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO
Pharma formulation firm Rubicon Research files draft papers for Rs 1,085-cr IPO
Zydus gets Mexican regulatory approval to market cancer treatment product
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant